2004
DOI: 10.1002/jcp.20027
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of vascular angiotensin II surface receptor regulation by epidermal growth factor

Abstract: We investigated mechanisms by which epidermal growth factor (EGF) reduces angiotensin II (AngII) surface receptor density and stimulated actions in vascular smooth muscle cells (VSMC). EGF downregulated specific AngII radioligand binding in intact cultured rat aortic smooth muscle cells but not in cell membranes and also inhibited AngII-stimulated contractions of aortic segments. Inhibitors of cAMP-dependent kinases, PI-3 kinase, MAP kinase, cyclooxygenase, and calmodulin did not prevent EGF-mediated downregul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
3
0

Year Published

2005
2005
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 26 publications
1
3
0
Order By: Relevance
“…Movement of AT 1 receptors in and out of the cell surface is well-described and involves interactions with microtubules and other cytoskeleton elements (15,29,32). In the present study, the addition of the microtubular depolymerizing agent colchicine prevented the enhanced response of proximal tubule cells preincubated at pH 7.0 to ANG II and also disrupted the enhancement of cell surface expression of AT 1 receptors by low pH.…”
Section: Discussionsupporting
confidence: 50%
“…Movement of AT 1 receptors in and out of the cell surface is well-described and involves interactions with microtubules and other cytoskeleton elements (15,29,32). In the present study, the addition of the microtubular depolymerizing agent colchicine prevented the enhanced response of proximal tubule cells preincubated at pH 7.0 to ANG II and also disrupted the enhancement of cell surface expression of AT 1 receptors by low pH.…”
Section: Discussionsupporting
confidence: 50%
“…To determine if the active form of APC was needed to increase sprout formation, aortic sections were also treated with PC (10 μg/mL) with or without hirudin (50 nM) or APC-DEGR (10 μg/mL). In studies looking at EGFR, PI3K, and MMPs, pharmacological inhibitors, AG 1478 (10 μM;Biomol) [25], LY 294002 (10 μg/mL; Biomol) [26], and GM 6001 (10 μg/mL;Biomol) [27], respectively, were added to the aortic sections 30 minutes prior to the addition of APC (10 μg/mL). Every 24 h for 5 days, media from each well was removed and replaced with fresh conditioned media.…”
Section: Methodsmentioning
confidence: 99%
“…Treatment with EGF and bFGF causes down-regulation of the AT 1 R (Nickenig and Murphy, 1994;Ullian et al, 1997) and consequent reduction of Ang II-induced InsP production (Ullian et al, 2004). In addition, activation of EGF-R, PDGF-R, and insulin receptor signaling initiates intracellular pathways that inhibit the actions of ␣ 1b -adrenergic receptors (␣ 1b -ARs) by promoting their phosphorylation and decreasing their coupling to heterotrimeric G proteins (Medina et al, 2000;García-Sá inz et al, 2004).…”
mentioning
confidence: 99%